News, musings and commentary on pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525-3955
Wednesday, June 29, 2005
Bextra: Still suspended in Europe
Europe's drug agency concluded a review of COX-2 painkillers, and said on June 27, 2005 it will recommend the continued suspension of Pfizer Inc.'s Bextra drug.
The London-based European Medicines Agency said it would review the suspension of Bextra, which was first suspended in Europe and the United States in April, within one year.